Tech Company Financing Transactions
Inocucor Funding Round
Inocucor, operating out of Denver, secured $9.5 million from Pontifax AgTech, Cairn Investment Group and Cycle Capital.
Transaction Overview
Company Name
Announced On
1/9/2018
Transaction Type
Venture Equity
Amount
$9,500,000
Round
Series B
Investors
Pontifax AgTech (Lead Investor) (Benjamin Belldegrun)
Cycle Capital (Andrée-Lise Méthot)
Proceeds Purpose
Funds will enable Inocucor to accelerate its commercialization activities, through the increased production and marketing of its first- and second-generation biostimulant products, Synergro and Synergro Free.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
4600 South Ulster St. 1325
Denver, CO 80237
USA
Denver, CO 80237
USA
Phone
Website
Email Address
Overview
Inocucor Technologies develops sustainable biological products for the phyto-microbiome that are safe for people and protect our natural resources.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Donald Marvin
VP - Finance
David Sisk
VP - Human Resources
Bonita Sonderby
VP - Manufacturing
Ramesh Murugesan
VP - Marketing
Timothy Sturm
VP - Product Management
Laura McIntosh
VP - R & D
Shawn Semones
Browse more venture capital transactions:
Prev: 1/9/2018: Bison venture capital transaction
Next: 1/9/2018: peerfit venture capital transaction
Share this article
News on VC Transactions
We do our best to record every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs